Purpose: We describe novel and simple techniques for management of cases of atypical and complex ureteropelvic junction (UPJ) obstruction. Material and Methods: Three cases of atypical UPJ obstruction were operated laparoscopically. Calicovesicostomy, pyelovesicostomy and ureteropyelostomy were performed laparoscopically as per the merits of each case. The 4-port technique was followed for calicovesicostomy and pyelovesicostomy (two 10-mm ports, one each at the umbilicus and lateral border of ipsilateral rectus and two 5-mm ports, one each at the lateral border of the contralateral rectus and midway between umbilicus and symphysis pubis). Both anastomoses were stented with a suprapubically placed Foley catheter. Laparoscopic ureteropyelostomy was done with port sites similar to standard laparoscopic pyeloplasty. Two double-J stents were placed, one in each moiety. Results: Mean operating time was 180 min and intraoperative blood loss was negligible. There were no intraoperative complications. The patients recovered well from the surgery. Postoperative nephrostograms confirmed anastomotic patency and good drainage. On follow-up, patients are doing well and asymptomatic. Patients with calicovesicostomy and pyelovesicostomy were advised double voiding. Conclusions: In select cases of giant hydronephrotic kidneys, anastomosis of the bladder with the most dependent part of pelvicalyceal system ensures adequate drainage. In UPJ obstruction with ureteral duplication, ureteropyelostomy with two double-J stents can be performed with good functional results. Laparoscopic performance of these procedures is feasible and simple.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.